Cargando…

Src: Marker or Actor in Prostate Cancer Aggressiveness

A key question for urologic practitioners is whether an apparently organ-confined prostate cancer (PCa) is actually aggressive or not. The dilemma is to specifically identify among all prostate tumors the very aggressive high-grade cancers that will become life-threatening by developing extra-prosta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vlaeminck-Guillem, Virginie, Gillet, Germain, Rimokh, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135356/ https://www.ncbi.nlm.nih.gov/pubmed/25184116 http://dx.doi.org/10.3389/fonc.2014.00222

Ejemplares similares

Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management
por: Vlaeminck-Guillem, Virginie
Publicado: (2018)

When Prostate Cancer Circulates in the Bloodstream
por: Vlaeminck-Guillem, Virginie
Publicado: (2015)

BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy
por: Nougarède, Adrien, et al.
Publicado: (2018)

Clinical utility of the nuclear-localized AR-V7 biomarker for treatment choice in metastatic castration-resistant prostate cancer
por: Vlaeminck-Guillem, Virginie
Publicado: (2020)

Comparative Evaluation of Urinary PCA3 and TMPRSS2: ERG Scores and Serum PHI in Predicting Prostate Cancer Aggressiveness
por: Tallon, Lucile, et al.
Publicado: (2014)

RAS as Supporting Actor in Breast Cancer
por: Galiè, Mirco
Publicado: (2019)

The Androgen Receptor and Its Crosstalk With the Src Kinase During Castrate-Resistant Prostate Cancer Progression
por: Gao, Lin, et al.
Publicado: (2022)

Mitochondrial Ca(2+) uptake controls actin cytoskeleton dynamics during cell migration
por: Prudent, Julien, et al.
Publicado: (2016)

Redox regulation of EGFR steers migration of hypoxic mammary cells towards oxygen
por: Deygas, Mathieu, et al.
Publicado: (2018)

Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness
por: Parra, Nestor Andres, et al.
Publicado: (2017)

The association between serum lipid profile and the prostate cancer risk and aggressiveness
por: Suh, Jungyo, et al.
Publicado: (2023)

Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI
por: Bertelli, Elena, et al.
Publicado: (2022)

Actors on the Scene: Immune Cells in the Myeloma Niche
por: Leone, Patrizia, et al.
Publicado: (2020)

Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2016)

Novel serum proteomic biomarkers for early diagnosis and aggressive grade identification of prostate cancer
por: Wang, Ce, et al.
Publicado: (2022)

Identification of NAA40 as a Potential Prognostic Marker for Aggressive Liver Cancer Subtypes
por: Koufaris, Costas, et al.
Publicado: (2021)

Disadvantageous Socioeconomic Position at Specific Life Periods May Contribute to Prostate Cancer Risk and Aggressiveness
por: Madathil, Sreenath, et al.
Publicado: (2018)

Editorial: Combining multiple non-invasive images and/or biochemical tests to predict prostate cancer aggressiveness
por: Mayer, Rulon, et al.
Publicado: (2023)

MEN1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and β-catenin
por: Luo, Yakun, et al.
Publicado: (2021)

Differentially Expressed Androgen-Regulated Genes in Androgen-Sensitive Tissues Reveal Potential Biomarkers of Early Prostate Cancer
por: Altintas, Dogus Murat, et al.
Publicado: (2013)

Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers
por: Soundararajan, Rama, et al.
Publicado: (2018)

EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence?
por: Cheaito, Katia A., et al.
Publicado: (2019)

The scaffold protein menin is essential for activating the MYC locus and MYC‐mediated androgen receptor transcription in androgen receptor‐dependent prostate cancer cells
por: Luo, Yakun, et al.
Publicado: (2021)

Urinary marker panels for aggressive prostate cancer detection
por: Lih, Tung-Shing Mamie, et al.
Publicado: (2022)

Detection of Glycosylated Markers From Cancer Stem Cells With ColoSTEM Dx Kit for Earlier Prediction of Colon Cancer Aggressiveness
por: Blondy, Sabrina, et al.
Publicado: (2022)

Comparative Study of Monoexponential, Intravoxel Incoherent Motion, Kurtosis, and IVIM-Kurtosis Models for the Diagnosis and Aggressiveness Assessment of Prostate Cancer
por: Liu, Ying, et al.
Publicado: (2020)

Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation
por: Bergamini, Marco, et al.
Publicado: (2022)

HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma
por: Shao, Fengling, et al.
Publicado: (2022)

Data-Driven Modeling of Src Control on the Mitochondrial Pathway of Apoptosis: Implication for Anticancer Therapy Optimization
por: Ballesta, Annabelle, et al.
Publicado: (2013)

Computer-Aided Image Analysis and Fractal Synthesis in the Quantitative Evaluation of Tumor Aggressiveness in Prostate Carcinomas
por: Waliszewski, Przemyslaw
Publicado: (2016)

Molecular features of aggressive thyroid cancer
por: Elia, Giusy, et al.
Publicado: (2022)

Cellular processes of v-Src transformation revealed by gene profiling of primary cells - Implications for human cancer
por: Maślikowski, Bart M, et al.
Publicado: (2010)

New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers
por: Ried, Karin, et al.
Publicado: (2020)

Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca(2+) traffic and response to neoadjuvant chemotherapy
por: Duong, Minh Quang, et al.
Publicado: (2023)

Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT
por: Iocolano, Michelle, et al.
Publicado: (2020)

Sirtuin 7: a new marker of aggressiveness in prostate cancer
por: Haider, Romain, et al.
Publicado: (2017)

The Roles of Beclin 1 Expression in Gastric Cancer: A Marker for Carcinogenesis, Aggressive Behaviors and Favorable Prognosis, and a Target of Gene Therapy
por: Zheng, Hua-chuan, et al.
Publicado: (2020)

c-Src Increases the Sensitivity to TKIs in the EGFR-Mutant Lung Adenocarcinoma
por: Min, Weili, et al.
Publicado: (2021)

Targeting Aggressive Cancer Stem Cells in Glioblastoma
por: Seymour, Tracy, et al.
Publicado: (2015)

Editorial: Immunometabolism and therapeutic targeting of aggressive cancers
por: Ždralević, Maša, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1g1b6679l2l91ioqotutn1l952